Concepedia

Milton L. Hammond

ML

78

Publications

3.5K

Citations

36

H-Index

1976

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Karo Pharma (Sweden)

United States Military Academy

Milton L. Hammond is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineDrug DiscoveryBiochemistryMedicinal ChemistryNatural SciencesEndocrinologyPharmacotherapyBiomolecular EngineeringDrug Development

Publications per year

1976–2019

78

Publications

78

Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase

Jeffrey H. Toney, Gail G. Hammond, Paula M.D. Fitzgerald et al. · Journal of Biological Chemistry · 2001 · 200 citations · Full text

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

Timothy A. Blizzard, Helen Chen, Seongkon Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 158 citations · Full text

Molecular Pharmacology, Antimicrobial Drug Discovery, Pharmaceutical Chemistry +14

Cytochrome P450 3A4-Mediated Bioactivation of Raloxifene: Irreversible Enzyme Inhibition and Thiol Adduct Formation

Qing Chen, Jason S. Ngui, George A. Doss et al. · Chemical Research in Toxicology · 2002 · 156 citations

Gynecology, Pharmacotherapy, Experimental Pharmacology +20

6H-Benzo[c]chromen-6-one derivatives as selective ERβ agonists

Wanying Sun, L. D. Cama, Elizabeth T. Birzin et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 144 citations · Full text

Molecular Pharmacology, Derivatives, Functional Selectivity +7

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Katherine Young, Ronald E. Painter, Susan L. Raghoobar et al. · BMC Microbiology · 2019 · 120 citations · Full text

Rows per page

1–5 of 78